JPWO2019222520A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019222520A5
JPWO2019222520A5 JP2020564323A JP2020564323A JPWO2019222520A5 JP WO2019222520 A5 JPWO2019222520 A5 JP WO2019222520A5 JP 2020564323 A JP2020564323 A JP 2020564323A JP 2020564323 A JP2020564323 A JP 2020564323A JP WO2019222520 A5 JPWO2019222520 A5 JP WO2019222520A5
Authority
JP
Japan
Prior art keywords
composition
fak inhibitor
inhibitor
composition according
fak
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020564323A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021524849A (ja
JP7585045B2 (ja
JP2021524849A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/032697 external-priority patent/WO2019222520A1/en
Publication of JP2021524849A publication Critical patent/JP2021524849A/ja
Publication of JPWO2019222520A5 publication Critical patent/JPWO2019222520A5/ja
Publication of JP2021524849A5 publication Critical patent/JP2021524849A5/ja
Priority to JP2024102853A priority Critical patent/JP2024123220A/ja
Application granted granted Critical
Publication of JP7585045B2 publication Critical patent/JP7585045B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020564323A 2018-05-16 2019-05-16 瘢痕形成の減少の為の接着斑キナーゼ阻害剤の制御されたヒドロゲル送達 Active JP7585045B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024102853A JP2024123220A (ja) 2018-05-16 2024-06-26 瘢痕形成の減少の為の接着斑キナーゼ阻害剤の制御されたヒドロゲル送達

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862672513P 2018-05-16 2018-05-16
US62/672,513 2018-05-16
US201962848515P 2019-05-15 2019-05-15
US62/848,515 2019-05-15
PCT/US2019/032697 WO2019222520A1 (en) 2018-05-16 2019-05-16 Controlled hydrogel delivery of focal adhesion kinase inhibitor for decreased scar formation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024102853A Division JP2024123220A (ja) 2018-05-16 2024-06-26 瘢痕形成の減少の為の接着斑キナーゼ阻害剤の制御されたヒドロゲル送達

Publications (4)

Publication Number Publication Date
JP2021524849A JP2021524849A (ja) 2021-09-16
JPWO2019222520A5 true JPWO2019222520A5 (https=) 2022-05-23
JP2021524849A5 JP2021524849A5 (https=) 2022-05-23
JP7585045B2 JP7585045B2 (ja) 2024-11-18

Family

ID=68540759

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020564323A Active JP7585045B2 (ja) 2018-05-16 2019-05-16 瘢痕形成の減少の為の接着斑キナーゼ阻害剤の制御されたヒドロゲル送達
JP2024102853A Pending JP2024123220A (ja) 2018-05-16 2024-06-26 瘢痕形成の減少の為の接着斑キナーゼ阻害剤の制御されたヒドロゲル送達

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024102853A Pending JP2024123220A (ja) 2018-05-16 2024-06-26 瘢痕形成の減少の為の接着斑キナーゼ阻害剤の制御されたヒドロゲル送達

Country Status (8)

Country Link
US (1) US12178940B2 (https=)
EP (1) EP3793589B1 (https=)
JP (2) JP7585045B2 (https=)
CN (1) CN112384238A (https=)
AU (2) AU2019269608B2 (https=)
CA (1) CA3100352A1 (https=)
ES (1) ES2980620T3 (https=)
WO (1) WO2019222520A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2980620T3 (es) * 2018-05-16 2024-10-02 Univ Leland Stanford Junior Administración controlada en hidrogel de inhibidor de la cinasa de adhesión focal para disminuir la formación de cicatrices
WO2021194618A1 (en) * 2020-03-26 2021-09-30 The Board Of Trustees Of The Leland Stanford Junior University Methods for tissue regeneration and kits therefor
WO2022191812A1 (en) * 2021-03-08 2022-09-15 National Cheng Kung University Method of facilitating wound-induced hair follicle neogenesis, tissue regeneration and reducing wound stiffness
WO2023009439A1 (en) * 2021-07-30 2023-02-02 The Board Of Trustees Of The Leland Stanford Junior University Mechanotransduction disruption mediation in skin grafting methods and compositions for use in practicing the same
WO2024177758A1 (en) * 2023-02-24 2024-08-29 TauTona Group Research and Development Company, L.L.C. Wound dressing assembly
WO2025122385A1 (en) * 2023-12-08 2025-06-12 Purinomia Biotech, Inc. Methods and compositions for reducing scar formation and treating dermatological wounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3973420B2 (ja) 2001-12-28 2007-09-12 ライフケア技研株式会社 創傷被覆材の製造方法
EP1691745B1 (en) 2003-12-11 2011-02-02 Teikoku Pharma USA, Inc. Methods and compositions for treating skin wounds
KR101499080B1 (ko) 2006-08-03 2015-03-06 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 반흔 및/또는 켈로이드의 치료 또는 예방을 위한 디바이스 및 붕대와 그것을 위한 방법 및 키트
US9636362B2 (en) * 2010-03-04 2017-05-02 The Board Of Trustees Of The Leland Stanford Junior University Pullulan regenerative matrix
US9480772B2 (en) 2010-11-12 2016-11-01 Nissan Chemical Industries, Ltd. Gel sheet containing lipid peptide gelator and polymeric compound
US9655967B2 (en) * 2011-12-09 2017-05-23 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of focal adhesion kinase for control of scar tissue formation
US20140072613A1 (en) 2012-09-10 2014-03-13 Cynthia Lander Compositions and Methods for Treating Cutaneous Scarring
ES2980620T3 (es) * 2018-05-16 2024-10-02 Univ Leland Stanford Junior Administración controlada en hidrogel de inhibidor de la cinasa de adhesión focal para disminuir la formación de cicatrices

Similar Documents

Publication Publication Date Title
JP2021524849A5 (https=)
JP2024123220A5 (https=)
CA2845150C (en) Primary dressing for moist wound healing, and method for producing said primary dressing
CN108135702B (zh) 具有氧化固醇药物负载的植入物和使用方法
US10111783B1 (en) Silica fiber composition and method of use
JPWO2019222520A5 (https=)
CN107683130B (zh) 包括氧固醇的植入物和使用方法
WO2009157558A1 (ja) 鼓膜または外耳道再生剤
WO2009129000A2 (en) Rigid bone graft substitute
Ma et al. Mesenchymal stem cells and dental implant osseointegration during aging: from mechanisms to therapy
JP2018164789A5 (https=)
HUT75468A (en) Collagen preparation for the controlled release of active substances
CN102665765A (zh) 促进创伤愈合的组合物
CN112384238A (zh) 减少瘢痕形成的局部黏着激酶抑制剂的受控水凝胶递送
EP3197513A1 (en) Porous foams derived from extracellular matrix, porous foam ecm medical devices, and methods of use and making thereof
WO2012167261A2 (en) Compositions and methods for treating and preventing neointimal stenosis
JP2023155480A (ja) シリカ繊維組成物及び使用方法
KR20160056345A (ko) 나노 캐리어를 포함하는 생체 이식용 임플란트 및 이의 제조방법
JP2025148371A (ja) 有効成分を含む創傷治療および瘢痕管理製品、その製造方法および有用な製品
JPWO2023009439A5 (https=)
JPWO2020086812A5 (https=)
US20240165056A1 (en) Use of tamoxifen and related compounds to reduce breast implant capsule formation and capsular contracture
KR102571040B1 (ko) 임플란트 식립부의 골생성 유도용 조성물 및 그 제조방법
CN103751838B (zh) 一种载vegf多孔羟基磷灰石支架的制备方法
Hackett How to prevent and treat exuberant granulation tissue.